Blogs
Accelerated approval and accelerated withdrawal – will the new clinical trial guidance bring US closer to Europe?
Written by: Srishti Gupta, PhD; Senior Consultant Contact: sgupta@partners4access.com In March 2023, the Food and Drug Administration (FDA) published, a first of its kind, draft